S-Khan Lab works flexibly and responsively to achieve their goals and objectives, our research is focused on the interface of chemistry and biology, based on the experience and methodology of computational structural biology, and we hope to uncover the molecular mechanism of important protein in life sciences. In the era of artificial intelligent (AI) and computational research advancements, our focus is situated at the intersection of pivotal fields in bioinformatics and biomedicine, these areas include the computational investigation of post-translational modifications of proteins (PTMs), drug discovery and development, rational drug design, and the medicinal applications of phytochemicals. Utilizing methodologies like computer-aided drug design and structure-based drug design, our aim is to identify novel therapeutic targets and optimize drug candidates for a variety of viral diseases, with a specific focus on addressing cancer, HIV, Covid and so on. Furthermore, our research delves into the development of functional nanomaterials, including carbon nanomaterials, up-conversion nanoparticles, organic nanomaterials, and protein-based carriers, among others. These multifunctional composite nanostructures offer vast potential for innovative approaches in disease diagnostics and cancer therapeutics. The overarching objective of our research is to seamlessly integrate computational modeling with practical applications in biomedicine, thereby advancing personalized medicine and enhancing patient outcomes. Additionally, recognizing the crucial role of databases as the primary and essential step in research, we have consolidated all biological databases onto a single platform. This unified platform provides an easy way for the scientific community to access a wide range of scientific data across various life sciences research areas, including proteomics, systems biology, genomics, biochemistry, molecular biology, transcriptomics, and population genetics. We offer free and user-friendly access to scientific databases and tools, ensuring researchers can efficiently find the resources they need.

Shorty, the benefits of our research are.

Advancement in Biomedicine and Drug Development: Our focus is on computational study of protein modifications, drug discovery, and rational drug design can lead to the development of novel therapeutic targets and optimized drug candidates. This can contribute significantly to addressing health challenges such as cancer, HIV, and Covid-19, benefiting the health sector globally by providing more effective treatments.

Bioinformatics and Data Sharing: Our efforts to uncover molecular mechanisms and provide comprehensive open data sharing through platforms like HABD can enhance collaboration and knowledge exchange in the global scientific community. This can facilitate collaborations with researchers and institutions, fostering innovation and advancements in biomedicine and bioinformatics.

Functional Nanomaterials Development: Our research in functional nanomaterials, including carbon nanomaterials and protein-based carriers, can have applications in innovative disease diagnostics and therapeutic approaches. These advancements can contribute to the development of cutting-edge medical technologies.

Contribution to Personalized Medicine: By bridging computational modeling with practical applications in biomedicine, this work can contribute to the advancement of personalized medicine. This personalized approach can lead to more tailored and effective treatments for individuals, contributing to improved patient outcomes and healthcare efficiency.

For publication of results or other research benefits kindly cite the following article or contact Dr. Shahid Ullah

Status: Published

The HABD: Home of All Biological Databases Empowering Biological Research With Cutting-Edge Database Systems
Shahid Ullah, Wajeeha Rahman, Farhan Ullah, Anees Ullah, Gulzar Ahmad, Muhammad Ijaz, Hameed Ullah, Din Mohammad Sharafmal

Kindly click on the required altmetric